Skip to main content
LIFECORE BIOMEDICAL, INC. \DE\ logo

LIFECORE BIOMEDICAL, INC. \DE\ — Investor Relations & Filings

Ticker · LFCR ISIN · US5147661046 LEI · 549300EHBZ5OM9ND9O43 US Manufacturing
Open in API
Filings indexed 1,095 across all filing types
Latest filing 2026-05-06 Interim / Quarterly Rep…
Country US United States of America
Listing US LFCR

About LIFECORE BIOMEDICAL, INC. \DE\

https://www.lifecore.com/

Lifecore Biomedical is an integrated contract development and manufacturing organization (CDMO) that specializes in sterile injectable pharmaceutical drug products and medical devices. The company provides a full range of services, including specialty formulation, process development, aseptic filling, and final packaging, supporting products from clinical phases through to commercial supply. A key area of expertise is the handling of complex and highly viscous formulations. In addition to its CDMO capabilities, Lifecore is a primary producer of non-animal-sourced sodium hyaluronate (hyaluronic acid), offering it in various molecular weights and formats, including bulk material, hydrogels, and filled syringes and vials for diverse applications.

Recent filings

Filing Released Lang Actions
10-Q - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-06 English
8-K - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Filer)
Regulatory Filings Classification · 90% confidence The document is a U.S. SEC Form 8-K current report (not the actual earnings release or investor presentation itself). It furnishes a press release (Exhibit 99.1) and an investor presentation (Exhibit 99.2) under Item 2.02 and Item 7.01, respectively. It is therefore a regulatory filing, not the substantive report or presentation itself and falls into the fallback category for miscellaneous regulatory filings.
2026-05-06 English
4 - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Filer)
Director's Dealing
2026-03-03 English
8-K Filing
Board/Management Information Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated January 14, 2026. It announces the adoption of a new Incentive Bonus Plan by the Compensation Committee of the Board of Directors. The content focuses on management decisions regarding executive compensation plans and changes in officer arrangements. There are no financial statements or detailed financial performance data included. The primary subject is the appointment and compensatory arrangements of officers, which aligns with announcements about changes in senior management or board-related matters. Therefore, the document fits best under Board/Management Information (MANG). The document length is 4319 characters, which is relatively short and consistent with an announcement rather than a full report. No indication of earnings, audit, or other report types is present.
2026-01-16 English
8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated November 17, 2025. It specifically mentions that the company intends to use a presentation in discussions with investors and analysts, and that the presentation is furnished as Exhibit 99.1. The text states that the presentation will be posted on the company's website and is incorporated by reference. The document itself does not contain detailed financial statements or analysis but rather provides the presentation material. The length of the document is 3664 characters, which is relatively short and consistent with an announcement or furnishing of a presentation rather than a full report. According to the classification rules, this fits the category of an Investor Presentation (IP) rather than an Annual Report, Earnings Release, or other financial report. Therefore, the correct classification is Investor Presentation (IP).
2025-11-17 English
10-Q
Interim / Quarterly Report Q1 2025
2025-11-06 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.